Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Lung cancer remains the most commonly diagnosed cancer worldwide and the leading cause of cancer-related mortality. More than 80 % of all newly diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). Despite recent advances, 40 % of patients still have advanced disease at the moment of diagnosis. Clinical information, pathological diagnosis and molecular assessment are needed to guide the systemic therapy, whereas discussion within an experienced team is key to adequately select the most appropriate multidisciplinary strategies. The purpose of this article is to provide updated recommendations for the management of these patients.

Original publication

DOI

10.1007/s12094-013-1085-2

Type

Journal article

Journal

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Publication Date

12/2013

Volume

15

Pages

977 - 984

Addresses

Medical Oncology Department, Hospital General Universitario, Valencia, Spain.

Keywords

SEOM (Spanish Society of Medical Oncology), Humans, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Diagnostic Techniques and Procedures, Neoplasm Staging, Algorithms, Continuity of Patient Care